Skip To Main Content
Arlington Dermatology on Muck Rack

Arlington Dermatology

As seen in: Oxford University Press (OUP), SKIN The Journal of Cutaneous Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Arlington Dermatology’s profile

Articles by Arlington Dermatology

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study

|
By Arlington Dermatology, Sanova Dermatology
| Oxford University Press (OUP)
Up to 80% of patients with psoriasis experience scalp psoriasis.1–3 Compared with other forms of psoriasis, scalp psoriasis can pose a therapeutic challenge because the presence of hair affects application and penetration of topical treatments, and some formulations lack cosmetic appeal, are greasy and can be difficult to wash out.4,5 Patient dissatisfaction with scalp psoriasis therapies results in diminished adherence to treatment, which affects efficacy.4,6,7 Scalp psoriasis is associated...
Open in Who Shared Issue with article?

Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes | SKIN The Journal of Cutaneous Medicine

|
By Bruce E. Strober, April Armstrong, Michael Bukhalo, Arlington Dermatology
| SKIN The Journal of Cutaneous Medicine Verified
Main Article Content Keywords psoriasis, machine learning, clinical utility, biomarkers, transcriptomics, biologics Abstract Objective: This study (MATCH) was designed to assess the clinical utility of a machine-learning based tool (Mind.Px) that predicts patient response to the most common biologic drug classes used in the management of psoriasis patients. Methods: The MATCH study was designed to assess Mind.Px utility in physician decision making and patient outcomes.
Open in Who Shared Issue with article?
Show More